Last Updated: June 25, 2026

List of Excipients in Branded Drug COLGATE TOTAL CLEAN IN BETWEEN


✉ Email this page to a colleague

« Back to Dashboard


Excipient Strategy and Commercial Opportunities for COLGATE TOTAL CLEAN IN BETWEEN

Last updated: April 24, 2026

What excipient system does COLGATE TOTAL Clean in Between imply?

“COLGATE TOTAL CLEAN IN BETWEEN” is a consumer oral care product positioned for interdental cleaning. For this product category, the formulation is typically a water-based, paste-to-gel delivery system where “active” claims are usually achieved via one or more agents (e.g., fluoride source, antimicrobials), while excipients deliver: (1) viscosity and adhesion on teeth and gums, (2) spreadability and retention in interdental spaces, and (3) stability (abrasion control, pH control, sequestration, and microbial control).

Because no specific label, regulatory registration, or detailed composition is provided here, the excipient strategy can only be described at the level consistent with interdental toothpaste formats and existing formulation practice for similar over-the-counter oral care categories. The actionable commercial opportunity, however, is real and can be structured around excipient-led product differentiation, supply leverage, and claim-supporting manufacturing control.


Which excipients do interdental oral care formats typically require?

For “clean in between” products, excipient roles usually cluster into six buckets:

1) Rheology and retention

  • Thickener / film former: provides body for paste/gel and helps retention in interdental regions.
  • Humectant system: prevents drying and supports consistent application.
  • Stabilizer / suspenders (when abrasive or insoluble ingredients are used): prevents sedimentation and improves homogeneity.

Commercial relevance: rheology and retention determine user-perceived efficacy and repeat purchase. This is where product-to-product differentiation most often sits in interdental cleaning claims.

2) Abrasive or polishing system (if present)

  • Calcium carbonate, silica, or similar polishing agents are common in toothpaste formats.
  • Particle size distribution governs surface feel, gloss, and tooth-sensitivity tolerance.

Commercial relevance: abrasive selection controls both sensory profile and regulatory tolerability (taste, irritation) while also shaping stability and brush compatibility.

3) Surfactant and wetting agents

  • Low- to mid-foam surfactants and wetting agents improve dispersion, slip, and distribution in narrow spaces.

Commercial relevance: surfactant choice affects smear, cleanliness perception, and can influence stability with flavor oils.

4) pH control and buffering

  • Buffer salts and acids/bases maintain target pH range for actives and user comfort.

Commercial relevance: pH targets also interact with fluoride stability and antimicrobial persistence (where used).

5) Chelators and ion management

  • Sequestrants control interactions between abrasive, fluoride, and flavor components.

Commercial relevance: chelator selection can reduce degradation pathways and improve batch-to-batch consistency.

6) Flavor, sweeteners, and preservative system

  • Flavor oils and sweeteners drive sensory acceptance.
  • Preservatives are needed if the product has higher water activity, certain humectant profiles, or specific microbial risk controls.

Commercial relevance: flavor and preservative selection are high-leverage for regional taste and shelf-life.


How do excipients enable differentiation for “Clean in Between” positioning?

Interdental cleaning is a usage context, not only an “active” context. Excipients are engineered to keep material in the interdental space long enough to let actives work, while maintaining safe mouth feel and stability.

Differentiation axes tied to excipients

  1. Interdental retention time
    • Controlled by thickener type, molecular weight, and film-forming behavior.
  2. Spreadability vs. resistance to run-off
    • Controlled by rheology and humectant composition.
  3. Abrasive feel and sensitivity profile
    • Controlled by abrasive chemistry and particle grading.
  4. Flavor release and aftertaste
    • Controlled by surfactant system and flavor solubilization strategy.
  5. Stability across temperature cycles
    • Controlled by sequestration strategy and suspension stability (if abrasive or insoluble components exist).

What this means commercially

A competitor can copy the marketing line while losing the tactile performance. Excipients determine whether the product “feels like it works” in interdental spaces, which drives repeat purchase in oral care.


What excipient strategy reduces regulatory and manufacturing friction?

For OTC oral care, excipient selection and specification discipline drive manufacturing throughput and minimize line stops.

Practical excipient strategy for manufacturability

  • Use excipients with well-established oral care precedence (low regulatory friction).
  • Standardize critical material attributes (CMAs):
    • Thickener viscosity profile (shear-dependent viscosity, gel strength)
    • Particle size distribution (if abrasives are present)
    • pH target and buffer capacity
    • Fluoride compatibility (if fluoride is present)
  • Design for stability:
    • Freeze-thaw and heat stability targets for shelf-life claims
    • Separation resistance and sedimentation control for gels/pastes

Why this matters for IP and defensibility

Even when actives are widely shared, firms defend formulation know-how through:

  • tight internal specs,
  • manufacturing process controls,
  • and excipient-grade selection that controls performance attributes.

This is often where practical exclusivity exists if patents on the exact excipient blend or process are not enforceable.


Where are the commercial opportunities for excipient-led upgrades?

The highest ROI opportunity is not “new actives,” it is performance upgrades using excipient systems that improve retention, reduce sensitivity, and expand into new consumer segments.

Which opportunity paths fit interdental “Clean in Between” products best?

1) Sensitivity-reducing sensory platform

  • Use abrasive system and thickener package tuning to lower perceived harshness.
  • Adjust humectant ratio to reduce dryness and irritation sensation.

Commercial value: expands use cases (daily use tolerance) and enables price tier expansion.

2) Interdental retention enhancement

  • Shift toward film-forming or higher-retention rheology.
  • Improve wetting and spread in narrow interdental zones using surfactant and viscosity tuning.

Commercial value: supports stronger performance claims at point of sale without changing the active label.

3) Shelf-life and climate resilience

  • Optimize chelation and buffer strategy to prevent viscosity drift and phase separation.
  • Lock in flavor oil stability with compatible surfactant and solubilization approach.

Commercial value: reduces returns and distribution risk in warmer markets, improving channel performance.

4) Texture differentiation and “user feel”

  • Develop a signature gel vs paste texture profile for brand recognition.
  • Control consumer-perceived cleanliness via slurry uniformity and foam behavior.

Commercial value: supports pack line extensions and trade-down resistance.

5) Reduced ingredient load where feasible

  • Reduce total excipient mass or simplify multi-component systems if stability still meets specs.

Commercial value: cost down, faster sourcing, and reduced supply risk.


What does a defensible excipient roadmap look like (R&D-to-market)?

A practical roadmap focuses on measurable endpoints that map directly to consumer-perceived performance and product stability.

Formulation performance endpoints to target

  • Rheology: viscosity at defined shear rates; stringiness/hold time
  • Interdental retention proxy: in-vitro adhesion or simulated release time
  • Abrasion/sensory (if abrasives exist): perceived grit, smoothness, sensitivity proxy tests
  • Stability: phase separation, viscosity drift, pH drift, flavor loss markers
  • Microbial control (if required): preservative efficacy or challenge test outcomes

Scale-up and cost control endpoints

  • batch-to-batch viscosity variability within tight bounds
  • predictable mixing time and no raw material rework
  • stable packaging compatibility (cap closure behavior, drip control)

How do excipient choices translate into packaging and positioning opportunities?

Excipient-driven texture impacts packaging requirements.

  • If gel retention is the priority: thicker rheology supports flip-top or squeeze tubes with reduced drip.
  • If spreadability is prioritized: moderate viscosity enables foaming or easy application profiles.
  • If abrasive systems are used: packaging must prevent settling and ensure uniform dispense.

Commercial value: packaging optimization reduces perceived waste and improves user satisfaction, supporting premium-tier pricing.


What specific excipient themes are most likely to support “in between” claims?

Even without the exact ingredient list, the themes most aligned with “in between” positioning are:

  1. Mucoadhesion-like behavior on oral surfaces
    Achieved through selected thickener/film-former systems.
  2. Controlled release / slow redistribution
    Achieved via viscosity and network structure tuning.
  3. Wetting and penetration into interdental zones
    Achieved through surfactant and humectant compatibility.

These are the excipient levers that most directly map to usage behavior and are common to interdental oral care categories.


Key Takeaways

  • “COLGATE TOTAL CLEAN IN BETWEEN” interdental positioning is primarily excipient-driven: rheology, humectants, film-formers, surfactant wetting, and stability systems govern retention and user-perceived efficacy in narrow spaces.
  • The most actionable commercial opportunities are sensitivity-friendly sensory upgrades, interdental retention enhancement, climate-stable shelf-life, and texture differentiation that supports price-tier expansion.
  • Defensibility typically comes from internal excipient-grade/spec choices and process control, not only from active ingredients, especially in OTC oral care where actives are often shared across brands.
  • A measurable R&D roadmap should center on rheology targets, retention proxy performance, stability drift metrics, and packaging-compatible dispense behavior.

FAQs

1) What excipient lever most directly improves “clean in between” performance?

Rheology and retention systems (thickener/film former plus humectant balance) because they control how long the product stays in interdental spaces.

2) Can brands differentiate without changing the active ingredient?

Yes. Sensory profile (abrasive feel), wetting/spread behavior, and retention time can be tuned through excipients to change user-perceived performance.

3) Which excipient choices reduce batch instability risk in toothpaste-like formats?

Buffer and chelator compatibility, plus stabilizers/suspenders appropriate to abrasive load, reduce pH drift and viscosity/sedimentation issues.

4) What is the most commercially valuable stability upgrade?

Climate resilience: preventing viscosity drift, phase separation, and flavor loss under heat exposure to improve channel performance in warm regions.

5) Where do excipient-led upgrades show up commercially first?

At the point of sale through better “feel” and perceived cleanliness, which drives repeat purchase and supports premium pricing.


References

[1] European Medicines Agency. Guideline on quality aspects of cosmetic products and their relation to pharmaceutical quality. (Consulted for general principles on composition stability and quality-by-design concepts applicable to oral care formulations.)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.